Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: Effect of aminoguanidine

Journal of Applied Physiology

Volumn 80, Issue 1, 1996, Pages 271-277

  Scott, J A ^a   Machoun, M ^a   McCormack, D G ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

endothelium derived relaxing factor; endotoxin; lipopolysaccharide; N(G)nitro L arginine methyl ester; sepsis

Indexed keywords

AMINOGUANIDINE; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE;

ANIMAL TISSUE; AORTA CONSTRICTION; ARTERY TONE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASCULAR RING;

EID: 0030042370     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1996.80.1.271     Document Type: Article

References (29)

1. Beasley, D., R. A. Cohen, and N. G. Levinsky. Endotoxin inhibits contraction of vascular smooth muscle in vitro. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H1187-H1192, 1990.
2. Bigaud, M., G. Julou-Schaeffer, J. R. Parratt, and J.-C. Stoclet. Endotoxin-induced impairment of vascular smooth muscle contractions elicited by different mechanisms. Eur. J. Pharmacol. 190: 185-192, 1990.
3. Billiar, T. R., R. D. Curran, D. J. Stuehr, J. Stadler, R. L. Simmons, and S. A. Murray. Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes. Biochem. Biophys. Res. Commun. 168: 1034-1040, 1990.
4. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
5. Buga, G. M., J. M. Griscavage, N. E. Rogers, and L. J. Ignarro. Negative feedback regulation of endothelial cell function by nitric oxide. Circ. Res. 73: 808-812, 1993.
6. Cho, H. J., Q. Xie, J. Calaycay, R. A. Mumford, K. M. Swiderek, T. D. Lee, and C. Nathan. Calmodulin is a subunit of nitric oxide synthase from macrophages. J. Exp. Med. 176: 599-604, 1992.
7. Corbett, J. A., R. G. Tilton, K. Chang, K. S. Hasan, Y. Ido, J. L. Wang, M. A. Sweetland, J. R. Lancaster, J. R. Williamson, and M. L. McDaniel. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552-556, 1992.
8. Fink, M. P., L. D. Homer, and J. R. Fletcher. Diminished pressor response to exogenous norepinephrine and angiotensin II in septic, unanesthetized rats: evidence for a prostaglandin-mediated effect. J. Surg. Res. 38: 335-342, 1985.
9. Fleming, I., G. A. Gray, G. Julou-Schaeffer, J. R. Parratt, and J.-C. Stoclet. Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem. Biophys. Res. Commun. 171: 562-568, 1990.
10. Glauser, M. P., G. Zanetti, J.-D. Baumgertner, and J. Cohen. Septic shock: pathogenesis. Lancet 338: 732-735, 1991.
11. Griffiths, M. J. D., M. Messent, R. J. MacAllister, and T. W. Evans. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol. 110: 963-968, 1993.
12. Hattori, Y., and S. S. Gross. GTP cyclohydrolase-1 messenger RNA is induced by LPS in vascular smooth muscle - characterization, sequence and relationship to nitric oxide synthase. Biochem. Biophys. Res. Commun. 195: 435-441, 1993.
13. Julou-Schaeffer, G., G. A. Gray, I. Fleming, C. Schott, J. R. Parratt, and J.-C. Stoclet. Activation of the L-arginine-nitric oxide pathway involved in vascular hyporeactivity induced by endotoxin. J. Cardiovasc. Pharmacol. 17, Suppl. 3: S207-S212, 1991.
14. Martin, C. M., A. Yaghi, W. J. Sibbald, D. G. McCormack, and N. A. M. Paterson. Differential impairment of vascular reactivity of small pulmonary and systemic arteries in hyperdynamic sepsis. Am. Rev. Respir. Dis. 148: 164-172, 1993.
15. McKenna, T. M. Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility - association with vascular cytokine release. J. Clin. Invest. 86: 160-168, 1990.
16. ω-nitro-L-arginine methyl ester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin. J. Appl. Physiol. 71: 2026-2031, 1991.
17. Misko, T. P., W. M. Moore, T. P. Kasten, G. A. Nickols, J. A. Corbett, R. G. Tilton, M. L. McDaniel, J. R. Williamson, and M. G. Currie. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233: 119-125, 1993.
18. Mohamed, F., J. C. Monge, A. Gordon, P. Cernacek, D. Blais, and D. J. Stewart. Lack of role for nitric oxide (NO) in the selective destablilization of endothelial NO synthase mRNA by tumor necrosis factor-α. Arterioscler. Thromb. Vasc. Biol. 15: 52-57, 1995.
19. Moncada, S., and E. A. Higgs. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 21: 361-374, 1991.
20. Moncada, S., R. M. J. Palmer, and E. A. Higgs. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
21. Palmer, R. M. J., D. S. Ashton, and S. Moncada. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature Land. 333: 664-666, 1988.
22. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature Land. 327: 524-526, 1987.
23. Perrella, M. A., F. L. Hildebrand, Jr., K. B. Margulies, and J. C. Burnett, Jr. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function. Am J. Physiol. 261 (Regulatory Integrative Comp. Physiol. 30): R323-R328, 1991.
24. Rees, D. D., S. Cellek, R. M. J. Palmer, and S. Moncada. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone an insight into endotoxin shock. Biochem. Biophys. Res. Commun. 173: 541-547, 1990.
25. Rees, D. D., R. M. J. Palmer, R. Schulz, H. F. Hodson, and S. Moncada. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101: 746-752, 1990.
26. Schmidt, K., E. R. Werner, B. Mayer, H. Wachter, and W. R. Kukovetz. Tetrahydrobiopterin-dependent formation of endothelium-derived relaxing factor (nitric oxide) in aortic endothelial cells. Biochem. J. 281: 297-300, 1992.
27. Schoedon, G., N. Blau, M. Sehneeman, G. Flury, and A. Schaffner. Nitric oxide production depends on preceding tetrahydrobiopterin synthesis by endothelial cells: selective suppression of induced nitric oxide production by sepiapterin reductase inhibitors. Biochem. Biophys. Res. Commun. 199: 504-510, 1994.
28. Wolff, D. J., and A. Lubeskie. Aminoguanidine is an isoformselective, mechanism-based inactivator of nitric oxide synthase. Arch. Biochem. Biophys. 316: 290-301, 1995.
29. Yoshizumi, M., M. A. Perella, J. C. Burnett, Jr., and M.-E. Lee. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73: 205-209, 1993.